Podcast Series: Episode 8 on fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project

Making sure that the Hypo-RESOLVE results change the diabetes (research) landscape for the better, is one of our most important goals. For our last episode, we have invited Jens Heisterberg from Novo Nordisk and Ken Tait from our Patient Advisory Committee (PAC) to talk about the importance of establishing a dialogue with government officials.

You can subscribe to the show via Spotify or Apple Podcasts, so you will never miss an episode.

Thanks for listening!

Listen on Spotify
Listen on ApplePodcasts
Listen on Anchor

Episode 8: Fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project